Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
35%
ALSO IN PBE
PBE
27
HOLDINGS
63%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 5.2% | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.6% | 4.7% | 3.6% |
|
AMGEN INC | 3.5% | 5.1% | 3.5% |
|
ILLUMINA INC | 2.0% | 5.8% | 2.0% |
|
EXELIXIS INC | 2.0% | 2.3% | 2.0% |
FTXH Overweight Relative to PBE
|
JOHNSON & JOHNSON | 8.1% |
|
ABBVIE INC | 7.5% |
|
PFIZER INC | 7.3% |
|
MERCK & CO. INC. | 7.0% |
|
BRISTOL-MYERS SQUIBB CO | 6.0% |
|
VIATRIS, INC. | 4.3% |
|
BIOGEN IDEC INC | 3.7% |
|
ZOETIS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
REGENERON PHARMACEUTICALS | 3.1% |
FTXH Underweight Relative to PBE
|
ALNYLAM PHARMACEUTICALS INC | -6.4% |
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
ILLUMINA INC | -3.8% |
|
VERTEX PHARMACEUTICALS INC | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.7% |
|
ANAVEX LIFE SCIENCES CORP. | -3.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.1% |
|
AMICUS THERAPEUTICS INC | -3.1% |